Senior insider sale
See Remarks at XERIS BIOPHARMA HOLDINGS, INC. — senior position signals high conviction
$950.4K
120K shares
What this filing means
MCCULLOCH KEVIN plans to sell 120K shares of XERIS BIOPHARMA HOLDINGS, INC. valued at approximately $950.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006705
Officer· See Remarks
Since Mar 2026
120K
Shares to sell
$950.4K
Approx. market value
120K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
1/29/2024
120KTotal acquired120K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/29/2024 | Restricted Stock Units N/A | 120K | — |
| Total | 120K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
120K
Market value
$950.4K
7/1/2026
Total
Units
120K
Value
$950.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/1/2026 | 120K | $950.4K | NASDAQ | Planned |
| Total | 120K | $950.4K | ||